Dangers of Gardasil Documenting the Dangers of the Gardasil Vaccine

Another Australian girl suffers due to GARDASIL. PDF Print E-mail

TWO months ago, Jessica Lock was a typical 13-year-old - outgoing, healthy and happy.

Yet now she is a stranger in her own home, racked by an array of mysterious ailments.

A week after being administered in February with the anti-cervical cancer vaccine Gardasil at her school, the teenager began fainting and experiencing strong head pains - and her parents say she has lapsed into a semi-permanent, child-like state.

Mother Shelley Lock believes her daughter suffered a severe and extremely rare reaction to Gardasil but said public hospital staff had been unwilling to examine a link, with one doctor inferring Jessica's condition was psychosomatic.

"It is frustrating because she was completely healthy before this, she had no stress, had just started Year 8 and was meeting new friends, has a good family, so to have it inferred that it was just stress or psychological was very frustrating," Mrs Lock said.

Exhaustive tests ruled out other potential causes such as brain tumours. However, Jessica's condition continued to deteriorate.

"She had an episode where she didn't know we were mum and dad, she was hysterical and screaming and we rang Flinders while she was in that state and they said there was nothing they could do to treat her and to not bother bringing her in," Mrs Lock said.

"Every now and then she comes lucid. Like on Monday morning, she woke up and sat and cried for five minutes because she couldn't remember the whole weekend, so she has her moments where she is aware that things are not right."

Mrs Lock said she found online testimonials from the US and Australia by women and girls who say they have experienced similar symptoms after being given Gardasil.

 

 

Read more...
 
Aussie boys need HPV Vaccination PDF Print E-mail

AUSTRALIA must act quickly to vaccinate schoolboys against human papillomavirus (HPV) or risk lagging behind other developed countries, health experts say.

While Australia in 2007 was the first country to introduce the Gardasil vaccine free to girls aged 12 and 13, it is yet to recommend a similar program for boys.

Meanwhile, the US and Canada have recommended routine vaccination of males.

The Pharmaceutical Benefits Advisory Committee (PBAC) last year recommended the Gardasil vaccine be given to Australian boys aged 12 to 13 in a school-based program.

The Federal Government is considering the recommendation, but last year said it would not be introduced until 2013 at the earliest.

Marian Pitts, director of the Australian Research Centre in Sex, Health and Society at La Trobe University in Melbourne, said it was "unconscionable" that boys would be without the vaccine this year.

"Given that PBAC gave it the go-ahead, I'm disappointed that it's not being included for boys in this school year," Ms Pitts said.

"At the very least we are going to lose 12 months more ... before we get young men vaccinated and I think that's unconscionable.

"I would really like Australia to maintain its pre-eminence in this ... and I just feel we are losing that impetus."

A report by Australian researchers published this week in The Lancet Infectious Diseases journal showed mounting evidence that vaccinating males was effective in reducing cancer-causing HPV infections.

One of the report's authors, Melina Georgousakis from the National Centre for Immunisation Research & Surveillance, said clinical trials of the vaccine in 4000 men proved effective in reducing HPV infections and lesions, which can go on to cause cancer.

But the vaccine's ability to prevent cancer directly could not be determined by the trials (conducted in a different group of 600 men) because HPV-related cancer rates among men were so low and no cancer was detected.

Although incidences of HPV-related cancers among men is only around one per cent, the report said it was higher in homosexual and bisexual men (men who have sex with men, or MSM).

Incidences of anal cancer, for example, are 30 times higher in these groups than in other men, the report said.

"The incidence of anal cancer among MSM in Australia can be estimated to be similar to that of cervical cancer before the cervical cancer screening program was introduced," it said.

The report said because male vaccination reduced the risk of HPV infection, it could be assumed that transmission would be lowered among men and women who were not vaccinated.

 
New Guidelines Advise Less Frequent Pap Smears PDF Print E-mail

The annual Pap smear, a cornerstone of women’s health for at least 60 years, is now officially a thing of the past, as new national guidelines recommend cervical cancer screening no more often than every three years.

In recent years, some doctors and medical groups, including the American College of Obstetricians and Gynecologists in 2009, began urging less frequent screening for cervical cancer. Even so, annual Pap smear testing is still common because many women are reluctant to give up frequent screening for cervical cancer.

The new guidelines, issued on Wednesday by the United States Preventive Services Task Force, replace recommendations last issued in 2003 and use more decisive language to advise women to undergo screening less often. Other groups, including the American Cancer Society, released similar recommendations on Wednesday. The new guidelines were published in Annals of Internal Medicine.

“We achieve essentially the same effectiveness in the reduction of cancer deaths, but we reduce potential harm of false positive tests,” said Dr. Wanda Nicholson, a task force member and an associate professor of obstetrics and gynecology at the University of North Carolina at Chapel Hill. “It’s a win-win for women.”

Cost is not a factor in the task force recommendations. Instead, its members focus on the effectiveness of a screening test to reduce cancer deaths, balanced against the potential harms that accompany the screening. The worry about frequent Pap smear screening is that tests can result in a large number of false positives that lead to sometimes painful biopsies and put women at risk for pregnancy complications in the future, like preterm labor and low-birth-weight infants.

The new guidelines focus on four key areas, including frequency of screening, age at which women should begin screening, age at which women should stop screening, and testing for human papillomavirus, or HPV, which can cause cervical cancer.

Under the new recommendations, the task force says women should be screened with a Pap smear no more than every three years. In 2003, the language was weaker, recommending screening “at least every three years,” which left the door open for annual tests.

In addition, women now are advised to begin screening at age 21 regardless of sexual history, and the task force specifically recommends against screening women younger than 21. In 2003, the advice to women was to start screening within three years of sexual activity, but no later than 21.

The task force also recommends against screening women over the age of 65, as long as they have had adequate prior screening and are not otherwise at high risk for cervical cancer. That advice has not changed since 2003.

Finally, the group also recommends against regular HPV screening for anyone under 30. In 2003, the task force said it did not have enough evidence to make a recommendation about HPV testing. It now says the test is unnecessary because many women exposed to the virus will eventually eliminate the virus without any intervention.

“HPV in women under 30 is highly prevalent but also highly transient,” Dr. Nicholson said. “Women under 30 may get infected with HPV, but they have a high likelihood of clearing that infection on their own, and it not causing any long-term change to their cervical tissue.”

HPV testing should be used in certain cases where women receive atypical test results from a Pap smear. In addition, the task force said that women over 30 who do not want to undergo a Pap test every three years could instead opt for a Pap test every five years along with an HPV test.

The task force recommendations apply only to healthy women. They do not change the advice for women who have unusual symptoms, an unusual Pap test result or a history of dysplasia, cervical cancer, H.I.V. or other illnesses.

 

Article found here: http://well.blogs.nytimes.com/2012/03/14/new-guidelines-advise-less-frequent-pap-smears/?ref=health

 
Email us! PDF Print E-mail

Have you or your daughter had the HPV/Cervical Cancer vaccine?


Are you experiencing any changes in your health?


Do you want to be in contact with other people who have been suspectedly or otherwise adversely effected for support and to share ideas on where to go from here?


Please drop us a line via the email on this site. We are presently trying to maintain and expand our network of young women whos lives will never be the same in order to provide them with online support, friends and new ideas!

 

 

 

 

 

 
Video to promote HPV Vaccine shown in Class PDF Print E-mail

3rd Feb 2012

CANCER prevention advocates are calling for schools to play an online

video in class to promote HPV vaccination, saying more than a quarter

of schoolgirls are failing to complete the full course under the NIP.

The schools-based program of vaccination with Gardasil (CSL) was

introduced five years ago for girls aged 12 to 13.



Research by the HPV Register shows that only 73% of girls nationwide,

and 76% in Victoria, have had all three doses.



Cancer Council Victoria cancer screening programs manager Kate Broun

said an online video aimed at teenage girls had been developed to

encourage greater participation in the program.

Girls were not having the full dose because of barriers including

pain, fear of needles and lack of understanding about the purpose of

the vaccine, she said.



“Taking all three doses of the HPV vaccine is the best step young

teenage girls can take to reduce their risk of cervical cancer,” Ms

Broun said.



Research showed that since 2007 when the HPV immunisation program

started, the number of girls under the age of 18 years with high-grade

abnormal precancerous cervical cells has halved.

However the drop-off in full coverage suggested schools could play an

important role in promoting the benefits of the vaccination.

“We encourage all schools to play the online video in class to help

prepare students in the lead-up to HPV immunisation day,” she said.

The video depicts teens discussing why they need to have the vaccine

at a young age, prior to sexual activity.



Article and vid available here:

http://www.medicalobserver.com.au/news/online-video-to-promote-hpv-

vaccine?hash=ec41517e91d925942ce8c4526d1762ec-

88bd006fed1065b2f5c17f335be4f593&utm_medium=email&utm_campaign=Medical

+Observer+eNews+-+03022012&utm_content=Medical+Observer+eNews+-

+03

 
«StartPrev1234567NextEnd»

Page 1 of 7

Featured Articles

  • The pain from being adversely effected by Gardasil is something TDOG (Team at Dangers of Gardasil) have the unfortunate experience of knowing about all too well. Western Society as a whole, from 9 year old…

    Read more...
  • Vaccinations are something that, at the very least, should be a subject of personal choice. Mandating vaccinations for children to attend certain schools is a a low act but forcing families to submit to authorities…

    Read more...